Download PDFPDF
Prednisolone versus dexamethasone in croup: a randomised equivalence trial
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Strategies for preventing re-presentation in croup

    Dear Editor,

    Sparrow and Geelhoed's interesting article would suggest that prednisolone and dexamethasone are equally efficacious in the initial management of croup, when assessed by the average length of stay in the emergency department (114 vs 84 minutes, P=0.5).

    Dexamethasone, however, seems to reduce the rate of re-presentation. From our anecdotal experience in the British West Midlands, many of the c...

    Show More
    Conflict of Interest:
    None declared.